1 / 4

Global Pericardial Disease Market, Size, Share, Analysis Report & Forecast to 20

The global pericardial disease market is anticipated to grow at a CAGR of around 5.5% during the forecast period.

alfahadkhan2510
Download Presentation

Global Pericardial Disease Market, Size, Share, Analysis Report & Forecast to 20

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Pericardial Disease Market, Size, Share, Analysis Report & Forecast to 2026 Global Pericardial Disease Market Size, Growth Analysis Report, Forecast to 2027 Global Pericardial Disease Market Size, Growth Analysis Report, Forecast to 2027 Global Pericardial Disease Market: Report Based on Development, Scope, Share, Trends, Forecast to 2027 Global Pericardial Disease Segmentation, Outlook, Industry Report to 2021-2027 Market Trends | The global pericardial disease market is anticipated to grow at a CAGR of around 5.5% during the forecast period. Pericardial disease is a medical condition that involves swelling and irritation in the pericardium. The pericardium is a two-layer sac that separates the heart from surrounding structures and protects it from vibration and external shocks. The patient with heart surgeries and other related surgeries become more vulnerable to such diseases. The rising number of geriatric population and prevalence of cardiovascular diseases is the major factor for the growth of the market. According to the American College of Cardiology report, in 2019, CVD was the underlying cause of 9.6 million deaths among men and 8.9 million mortalities among women, around a third of all mortalities across the globe. Over 6 million of this mortality occurred in people between the ages of 30-70. The highest number of CVD deaths occurred in China, followed by India, Russia, the US and Indonesia. Additionally, prevalent cases of total CVD nearly doubled from 271 million in 1990 to 523 million in 2019, and the number of CVD mortalities steadily increased from 12.1 million in 1990, reaching 18.6 million in 2019. Get Free Sample Copy @ https://www.omrglobal.com/request-sample/pericardial-disease- market

  2. The global pericardial disease market is segmented based on type, diagnosis method, and treatment approach. Based on type the market is sub-segmented into acute pericarditis, chronic pericarditis, and recurrent pericarditis. Based on the diagnosis method, the market is segregated into chest X-Ray, cardiac MRI, cardiac CT scan, echocardiography, electrocardiography, and others (blood test). Whereas, on the basis of treatment, the market is bifurcated into NSAIDS drugs and pericardiectomy. The NSAIDS drug segment is anticipated to grow with significant market share during the forecast period. Nonsteroidal anti-inflammatory drugs are the first-line treatment for pericardial effusion caused by inflammation. The significant use of these drugs during the pericardial treatment will create its demand in the market, which will further drive the market growth. A https://www.omrglobal.com/industry-reports/pericardial-disease-market Full Report of Global Pericardial Disease Market is Available at: Geographically, the global pericardial disease market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, ASEAN and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Asia-Pacific is projected to witness the fastest growth in the global pericardial disease market due to the rapid development of the healthcare industry and the rising cases of diseases due to sedentary lifestyles. Global Pericardial Disease Market– Segmentation By Type •Acute Pericarditis •Chronic Pericarditis •Recurrent Pericarditis By Diagnosis Method •Chest X-Ray •Cardiac MRI •Cardiac CT scan •Echocardiography •Electrocardiography •Others (Blood Test) By Treatment Approach

  3. •Non-steroidal Anti-Inflammatory Agents (NSAIDS) Drugs •Pericardiectomy Global Pericardial Disease Market – Segmentation by Region North America •United States •Canada Europe •Germany •United Kingdom •France •Spain •Italy •Rest of Europe Asia-Pacific •China •Japan •India •Rest of Asia-Pacific Rest of the World Company Profiles •Abbott Laboratories •AliveCor, Inc. •AstraZeneca PLC •Bayer AG •CardioComm Solutions, Inc. •Coloplast Corp. •CryoLife, Inc. •Edwards Lifesciences Corp.

  4. •General Electric Co. •Integra LifeSciences Corp. •Kiniksa Pharmaceuticals, Ltd. •LivaNova PLC •Merck & Co., Inc. •Teva Pharmaceutical Industries Ltd. •VectraCor Inc. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pericardial-disease-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related